Lifecare ASA (FRA:LFC0) Total Equity: €2.59 Mil (As of Mar. 2026)

What is Lifecare ASA Total Equity?

Lifecare ASA FRA:LFC0 8 Total Equity is €2.59 Mil as of Mar. 2026. GuruFocus rates FRA:LFC0 with a GF Score™ of 8/100 and a GF Value™ of €0.01 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Lifecare ASA's total equity for the quarter that ended in Mar. 2026 was €2.59 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Lifecare ASA Total Equity Related Terms

Lifecare ASA Total Equity Historical Data

* Premium members only.

The historical data trend for Lifecare ASA's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lifecare ASA Total Equity Chart

Lifecare ASA Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Equity

Get a 7-Day Free Trial

2.39

5.39

5.78

6.30

-2.37

Lifecare ASA Quarterly Data
	Jun19	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Total Equity	Get a 7-Day Free Trial															4.63	5.08	-0.57	-2.37	2.59

8GF Score

Lifecare ASA FRA:LFC0

Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Lifecare ASA Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Lifecare ASA's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2025 )	-	Total Liabilities(Q: Dec. 2025 )
	=	8.031	-	10.4
	=	-2.37

Lifecare ASA's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity	=	Total Assets(Q: Mar. 2026 )	-	Total Liabilities(Q: Mar. 2026 )
	=	8.183	-	5.599
	=	2.58

Frequently Asked Questions Learn more about Total Equity →

What does a Total Equity of €2.59 Mil mean?

Lifecare ASA (FRA:LFC0) has a Total Equity of €2.59 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Lifecare ASA and its competitors.

Is Lifecare ASA's Total Equity too high?

Lifecare ASA's current Total Equity is €2.59 Mil. Overall, Lifecare ASA has a GF Score™ of 8/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Lifecare ASA's Total Equity compare to ABT and SYK?

Lifecare ASA's Total Equity of €2.59 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Equity for a Medical Devices & Instruments company?

A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Equity mean?

A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Lifecare ASA and its competitors. Lifecare ASA's current Total Equity is €2.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Lifecare ASA stock overvalued right now?

Based on GuruFocus' analysis, Lifecare ASA (FRA:LFC0) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.01, compared to a current price of €0.03 — trading 150% above its estimated fair value. The current Total Equity is €2.59 Mil. Lifecare ASA's overall GF Score™ is 8/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Equity calculated?

Total Equity is calculated from a company's financial statements. For Lifecare ASA (FRA:LFC0), the current Total Equity is €2.59 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lifecare ASA (FRA:LFC0) Overvalued in 2026?

Based on GuruFocus' analysis, Lifecare ASA stock appears to be overvalued. The current stock price of €0.03 is trading 150% above its estimated GF Value™ of €0.01. GuruFocus considers Lifecare ASA to be Significantly Overvalued.

Key valuation signals for FRA:LFC0:

Total Equity: €2.59 Mil
GF Value™: €0.01 vs. price of €0.03 (150% above fair value)
GF Score™: 8/100 with 6 warning signs

No single metric tells the full story. See the FRA:LFC0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lifecare ASA Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies OSL:OBSRV OSL:GENT ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760 STE ZBH XSWX:SOON LSE:SN.PEN SHSE:688271 GMED TSE:7733

Other Exchanges LIFE:Norway LFC0:Germany

Address Ytrebygdsvegen 215, Blomsterdalen, Bergen, NOR, 5258

Website https://www.lifecare.no

Lifecare ASA is a medical sensor company developing technology for sensing and monitoring of various body analytes. It is focused on advancing continuous glucose monitoring systems and uses osmotic pressure as a sensing method. Its technology can be applied to detect and monitor various analytes and molecules in humans and animals. The company operates as a single segment focused on research and development (R&D) of its osmotic pressure sensor and related components.

8GF Score

Get the complete analysis for FRA:LFC0

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03

Price

€0.01

GF Value

View FRA:LFC0 Analysis

See Total Equity data for all stocks →